A recent study suggests that individuals who stop using new slimming jabs like semaglutide or tirzepatide tend to recover shed pounds much more quickly than those who stop traditional lifestyle plans.
Published data in a major health publication points out that while obese people frequently drop a large proportion of their body weight while on the medication, the weight comes back at an average rate of nearly a kilo each month after stopping.
"Users using such medications must be informed of the potential of quick weight regain when the medication is stopped," warns researcher Dr. Susan Jebb.
This pace of recovery means a reversion to pre-treatment mass within about one and a half years.
Weighing Therapies
The research, which looked at dozens of trials involving over 9,000 of participants, contrasted the effects of GLP-1 agonists with older methods.
Scientists emphasize that individuals who lose weight through diet and exercise generally have a slower weight regain—around 0.1 kg a month—after stopping.
The Reason for the Quick Regain
Doctors propose the way of the injections is key to understanding the amplified weight return.
These medications imitate a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Artificially providing GLP-1 levels several times higher than normal could lead to the system to produce less of its own natural GLP-1, and could diminish responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Stopping of this GLP-1 'fix' leads to hunger is uncontrolled, making overeating much more probable."
A Lifelong Issue?
Health authorities advise the jabs for individuals with weight-linked health risks, alongside prescribed lifestyle changes.
A number of clinicians contend that, considering the significant potential of relapse, the treatment might need to be long-term.
This perspective is echoed by pharmaceutical companies, who note that the findings "highlight the long-term character of excess weight," similar to managing diseases like diabetes.
User Experiences
Users who have discontinued the medication describe a powerful resurgence of appetite.
"It felt as if a trigger flipping and I was suddenly extremely hungry," said a patient.
The struggle is worsened if users have not developed lasting lifestyle or habit changes during treatment.
Significant Use
Recent estimates indicate that millions of people in the UK have used weight-loss jabs in the past year, with interest continuing to grow.
- Adoption is more common among females compared to men.
- The middle-aged age group shows the greatest usage rates.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, experts emphasize that while GLP-1 drugs are potent tools for shedding pounds, they are not a permanent cure and lasting health benefits likely depends on ongoing lifestyle management.
